| 1 |
Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022[J]. J Natl Cancer Cent, 2024, 4(1): 47-53.
|
| 2 |
汪晓东，吕炘沂，刘健博，等. 数据库研究第七部分：结直肠癌手术的特征(二)[J]. 中国普外基础与临床杂志，2020, 27(11): 1418-1425.
|
| 3 |
李微，彭丽华，张玲，等. 结直肠癌术后肺部感染危险因素的范围综述[J]. 循证护理，2023, 9(4): 626-630.
|
| 4 |
林福臻，唐志良，梁敏玲. 腹腔镜结直肠癌根治术后发生肺部感染的病原学及影响因素Logistic回归分析[J]. 数理医药学杂志，2022, 35(4): 536-539.
|
| 5 |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263.
|
| 6 |
Sung H, Ferlay J, Siegel R, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: A Cancer Journal for Clinicians, 71(3): 209-249.
|
| 7 |
Baidoun F, Elshiwy K, Elkeraie Y, et al. Colorectal cancer epidemiology：recent trends and impact on outcomes[J]. Curr Drug Targets, 2021, 22(9): 998-1009.
|
| 8 |
Kato I, Sun J. Microbiome and diet in colon cancer development and treatment[J]. Cancer J, 2023, 29(2): 89-97.
|
| 9 |
Zhang XL, Zhang XF, Fang Y, et al. A possible genetic association between obesity and colon cancer in females[J]. Front Endocrinol (Lausanne), 2023, 14: 1189570.
|
| 10 |
刘怡彤，孙洋. 结肠炎癌转化调控机制和化学干预的研究进展[J]. 药学学报，2022, 57(5): 1273-1281.
|
| 11 |
Na HK, Lee JY. Molecular basis of alcohol-related gastric and colon cancer[J]. Int J Mol Sci, 2017, 18(6): 1116.
|
| 12 |
Lynch HT, de la Chapelle A. Hereditary colorectal cancer[J]. N Engl J Med, 2003, 348(10): 919-932.
|
| 13 |
Garcia-Aguilar J, Patil S, Gollub MJ, et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy[J]. J Clin Oncol, 2022, 40(23): 2546-2556.
|
| 14 |
Julien AMV, Mohamed EA, Laura AMD, et al. Cost-effectiveness of general practitioner-versus surgeon-led colon cancer survivorship care: an economic evaluation alongside a randomised controlled trial[J]. J Cancer Surviv, 2024, 18(4): 1393-1402.
|
| 15 |
丁世洁，郑紫恒，刘欣，等. 规范化营养干预对结肠癌患者化疗效果的影响[J]. 中国药物滥用防治杂志，2023, 29(3): 457-459，466.
|
| 16 |
Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients[J]. Clinical Nutrition, 2017, 36(1): 11-48.
|
| 17 |
Vornholz L, Isay SE, Kurgyis Z, et al. Synthetic enforcement of STING signaling in cancer cells appropriates the immune microenvironment for checkpoint inhibitor therapy[J]. Sci Adv, 2023, 9(11): eadd8564.
|
| 18 |
Segal BH, Freifeld AG, Baden LR, et al. Prevention and treatment of cancer-related infections[J]. J Natl Compr Canc Netw, 2008, 6(2): 122-174.
|
| 19 |
Crisafulli G, Sartore-Bianchi A, Lazzari L, et al. Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients[J]. Cancer Discov, 2022, 12(7): 1656-1675.
|
| 20 |
Feng Q, Yuan W, Li T, et al. Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial[J]. Lancet Gastroenterol Hepatol, 2022, 7(11): 991-1004.
|
| 21 |
Meduri GU, Shih MC, Bridges L, et al. Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia[J]. Intensive Care Med, 2022, 48(8): 1009-1023.
|
| 22 |
范春丽，裴王伟，骆丰.18152例消化系统恶性肿瘤患者贫血情况分析[J]. 中国卫生检验杂志，2021, 31(1): 105-108.
|
| 23 |
Demb J, Kolb JM, Dounel J, et al. Red flag signs and symptoms for patients with early-onset colorectal cancer: a systematic review and meta-analysis[J]. JAMA Netw Open, 2024, 7(5): e2413157.
|
| 24 |
童昕，孙雄，蒋祈，等. 结直肠癌患者的贫血发生率及其影响因素分析[J]. 中国普外基础与临床杂志，2021, 28(8): 1003-1008.
|
| 25 |
Fearon K, Strasser F, Anker SD. Definition and classification of cancer cachexia: an international consensus.[J]. Lancet Oncology, 2011, 12(5): 489-495.
|
| 26 |
Weiss G, Ganz T, Goodnough LT. Anemia of inflammation[J]. Blood, 2019, 133(1): 40-50.
|
| 27 |
Akce M, Farran B, Switchenko JM, et al. Phase Ⅱ trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer[J]. J Immunother Cancer, 2023, 11(10): e007235.
|
| 28 |
Prager GW, Taieb J, Fakih M, et al. Trifluridine-tipiracil and bevacizumab in refractory metastatic colorectal cancer[J]. N Engl J Med, 2023, 388(18): 1657-1667.
|
| 29 |
秦垠，刘莲芳，钱伟华，等. 贫血对接受免疫治疗的晚期实体瘤患者预后的影响[J]. 中国现代药物应用，2024, 18(3): 75-77.
|
| 30 |
Tamini N, Deghi G, Gianotti L, et al. Colon cancer surgery: does preoperative blood transfusion influence short-term postoperative outcomes？[J]. J Invest Surg, 2021, 34(9): 974-978.
|
| 31 |
Talboom K, Borstlap WAA, Roodbeen SX, et al. Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): a multicentre, open-label, randomised, controlled trial[J]. Lancet Haematol, 2023, 10(4): e250-e260.
|